Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $353.9952W HIGH $556.52
Volume
1.12 M
Value Traded
428.50 M
Short % Float
3.39%
Days to Cover
4.6
+1.7%Week
+11.76%1 Month
+16.37%3 Month
+10.77%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
102.45 B
EPS (TTM)
31.30
P/E Ratio
15.12
Ent. Value
146.30 B
Total Shares
216.58 M
Float Shares
144.67 M
Insiders
33.18%
Institutions
62.95%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
HCA Catalyst Timeline
Dated clinical, regulatory and corporate events for HCA Healthcare, Inc.
Catalyst Timeline
Dated clinical, regulatory & corporate events for HCA Healthcare, Inc.
6Total events
0Upcoming
0Tier-1 (high impact)
2026 to 2026Coverage
Event history 5
◆PublicationPresentation
NEJM study publication on CRISPR-based therapy for children
CRISPR-based therapy for childrensource ↗
Past FDA Catalysts and PDUFA Decisions
How HCA actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
HCA Healthcare, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every HCA program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Marks Mike AOfficer (EVP and CFO) | Disposition | -3,336 | $0.00 | 05/07/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in HCA
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| PFM HEALTH SCIENCES, LP | 0.3 % (-50 %) | 3.23 M | 8.29 K | -37.87% ( -5.06 K) |
HCA Institutional Ownership Trends
HCA Short Interest
Shares sold short, counted twice a month.
3.39%
Short % of Float
of tradable shares sold short
4.9M
Shares Sold Short
+0.4% vs prior count
4.6 Moderate
Days to Cover
trading days of normal volume to buy every short share back
1.1M
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How HCA ranks across every disease it competes in
Competitive Position is a premium feature
See how HCA ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialHCA News
-HCA
Oct 29, 2026▼ -1%today
More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care
HCA Healthcare reported that 102 of its hospitals earned Healthgrades recognition for specialty care excellence, the highest count among U.S. health systems. The 2027 awards reflect clinical outcomes in surgical care, emergency medicine, and orthopedic surgery. This distinction helps patients and families make informed healthcare decisions.
Read more →-HCA
Oct 27, 2026▼ -1%today
HCA Healthcare Reports Third Quarter 2026 Results
HCA Healthcare reported third quarter results for 2026, revealing a 3.6% revenue increase to $19.849 billion. However, net income dropped 3.9% to $1.579 billion. Despite challenges like a payer mix shift affecting income, the company saw growth in admissions and earnings per share. HCA expects to meet its full-year guidance.
Read more →-HCA
Oct 21, 2026HCA Healthcare to Host Eighth Annual “Crush the Crisis” National Prescription Drug Take Back Day
HCA Healthcare announced its eighth annual 'Crush the Crisis' national prescription drug take back day, scheduled for October 24, 2026. The event will involve partnerships with local law enforcement to facilitate the safe disposal of unused medications. More than 130 collection sites will be set up across the country.
Read more →-HCA
Sep 30, 2026HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call
HCA Healthcare, Inc. has announced its 3rd Quarter 2026 Earnings Conference Call, scheduled for October 27, 2026. The call will be accessible via a live audio webcast, allowing investors to participate remotely. The company aims to provide insights into its financial performance during this session.
Read more →-HCA
Sep 29, 2026HCA Healthcare Presents 2026 Awards of Distinction
HCA Healthcare held its annual Awards of Distinction ceremony in Nashville, honoring exceptional individuals within the organization. The awards, including the Frist Humanitarian Award and the Excellence in Nursing Award, recognize the dedication and contributions of colleagues, nurses, physicians, and volunteers. This event highlights HCA's commitment to excellence in healthcare.
Read more →-HCA
Sep 29, 2026SOLIS MAMMOGRAPHY AND HCA HEALTHCARE CHARLESTON PARTNER TO EXPAND BREAST HEALTH SERVICES IN SOUTH CAROLINA
Solis Mammography has partnered with HCA Healthcare Trident Hospital to enhance breast health services in Charleston, South Carolina. This joint venture marks Solis Mammography's first location in the state, aiming to improve access to essential screening and diagnostic services. The collaboration will utilize advanced technology and a patient-first approach to support women's healthcare in the region.
Read more →-HCA
Sep 15, 2026HCA Healthcare Completes Acquisition of the College of Health Care Professions
HCA Healthcare has successfully completed its acquisition of The College of Health Care Professions. This strategic move aims to enhance the training and development of future healthcare professionals, addressing the evolving needs of communities. The acquisition is expected to improve access to skilled caregivers in the healthcare sector.
Read more →-HCA
Sep 14, 2026MEDITECH Expanse EHR Live Across First Full U.S. Divisions of HCA Healthcare
MEDITECH has successfully implemented its Expanse EHR platform in 34 hospitals within HCA Healthcare's Capital and North Florida divisions. This rollout marks a significant step in enhancing healthcare delivery and patient care through advanced electronic health record systems. The completion of this implementation is expected to improve operational efficiencies across these facilities.
Read more →-HCA
Aug 20, 2026▲ +5.6%on this news
HCA Healthcare, Inc. to Present at September Conferences
HCA Healthcare, Inc. is set to present at two significant healthcare conferences in September 2026. The presentations will take place on September 9 at the Wells Fargo Healthcare Conference and on September 15 at the Jefferies Healthcare Conference. Investors can access live audio webcasts and presentation materials through the company's website.
Read more →-HCA
Aug 6, 2026HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group
HCA Healthcare has appointed Dr. Michael Schlosser as the new Executive Vice President and Chief Clinical Officer, effective September 1, 2026. Charles Gressle has also been named the President of the newly established Ambulatory Operations Group. These leadership changes are expected to enhance the company's clinical operations and patient care.
Read more →-HCA
Jul 24, 2026HCA Healthcare Reports Second Quarter 2026 Results
HCA Healthcare, Inc. reported its financial results for the second quarter of 2026, revealing an 8.7% increase in revenues compared to the same quarter in 2025. The company's net income attributable metrics were also highlighted, aligning with prior guidance shared on July 14, 2026. Overall, the results indicate a strong performance for the quarter.
Read more →-HCA
Jul 14, 2026▼ -6.9%on this news
HCA Healthcare, Inc. 2nd Quarter 2026 Earnings Conference Call
HCA Healthcare, Inc. has scheduled its 2nd Quarter 2026 Earnings Conference Call for July 24, 2026. The call will be accessible via live audio webcast, allowing investors to listen in on the company's financial performance. The event emphasizes HCA's commitment to investor relations and transparency.
Read more →-HCA
Jul 14, 2026▼ -6.9%on this newsshared move
HCA Healthcare Previews Second Quarter 2026 Results
HCA Healthcare, Inc. has announced preliminary financial results for the second quarter of 2026, projecting revenues of approximately $20.230 billion, a significant increase from $18.605 billion in the same quarter of 2025. The net income attributable to HCA Healthcare is also expected to reflect positive growth. These results are subject to finalization through the company's accounting procedures.
Read more →-HCA
Jun 29, 2026HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children
HCA Healthcare has announced a study published in the New England Journal of Medicine that focuses on advancements in CRISPR-based therapy for children. The study highlights significant progress in this innovative treatment approach. However, details regarding the specific findings or implications of the study were not disclosed in the announcement.
Read more →-HCA
May 27, 2026HCA Healthcare Announces Agreement to Acquire The College of Health Care Professions
HCA Healthcare has announced an agreement to acquire The College of Health Care Professions. This acquisition aims to enhance HCA's educational offerings and workforce development. Further details regarding the transaction and its implications for both organizations have not been disclosed.
Read more →-HCA
May 19, 2026HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative
HCA Healthcare colleagues participated in an annual Days of Service initiative, contributing over 41,800 hours of volunteer work. This effort highlights the company's commitment to community service and employee engagement. The initiative not only benefits local communities but also strengthens teamwork among employees.
Read more →-HCA
Apr 30, 2026HCA Healthcare, Inc. to Present at May Conference
HCA Healthcare, Inc. is scheduled to present at the RBC Global Healthcare Conference on May 20, 2026, at 11:30am ET. The presentation will be accessible via a live audio webcast, with materials available on the company's Investor Relations website. HCA Healthcare operates 189 hospitals and approximately 2,600 ambulatory care sites across 19 states and the UK.
Read more →-HCA
Apr 27, 2026HCA Announces Proposed PUBLIC Offering of Senior Notes
HCA Healthcare, Inc. announced a proposed public offering of senior notes by its wholly owned subsidiary, HCA Inc. The terms of the notes, including maturity and interest rates, will depend on market conditions at the time of pricing. The net proceeds from the offering are intended for general corporate purposes, potentially including repayment of existing borrowings. Several prominent financial institutions are acting as joint book-running managers for this offering.
Read more →-HCA
Apr 27, 2026HCA Healthcare Names Cynthia Cifuentes-Finkel Senior Vice President of Marketing and Corporate Affairs
HCA Healthcare has appointed Cynthia Cifuentes-Finkel as the new Senior Vice President of Marketing and Corporate Affairs. This strategic move is aimed at enhancing the company's marketing efforts and corporate communications. Cifuentes-Finkel's extensive experience is expected to contribute positively to HCA's initiatives.
Read more →-HCA
Apr 24, 2026▼ -8.8%on this newsshared move
HCA Healthcare Reports First Quarter 2026 Results
HCA Healthcare reported its first quarter 2026 results, showing a revenue increase of 4.3% to $19.109 billion and a net income rise of 0.6% to $1.620 billion. Despite challenges such as a 42% drop in respiratory-related admissions and adverse weather impacts, the company experienced significant cash flow growth. The board declared a quarterly cash dividend of $0.78 per share, reinforcing its commitment to shareholders.
Read more →About HCA Healthcare, Inc.
HeadquartersONE PARK PLZ, NASHVILLE, TN, 37203
BIOPHARMAWATCH ELITE PLUS
Trade the next HCA catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime